HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

valspodar (PSC 833)

nonimmunosuppressive cyclosporin analog which is a potent multidrug resistance modifier; 7-10 fold more potent than cyclosporin A; a potent P glycoprotein inhibitor; MW 1215
Also Known As:
PSC 833; 3'-keto-Bmt(1)-Val(2)-cyclosporin A; PSC-833; PSC833; SDZ PSC 833; SDZ-PSC-833
Networked: 178 relevant articles (13 outcomes, 58 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Sikic, Branimir I: 5 articles (05/2017 - 03/2004)
2. Larson, Richard A: 4 articles (09/2010 - 08/2002)
3. Kankesan, Janarthanan: 4 articles (03/2006 - 08/2003)
4. Ling, Victor: 4 articles (03/2006 - 08/2003)
5. Rajalakshmi, Srinivasan: 4 articles (03/2006 - 08/2003)
6. Rao, Prema M: 4 articles (03/2006 - 08/2003)
7. Sarma, Dittakavi S R: 4 articles (03/2006 - 08/2003)
8. Thiessen, Jake J: 4 articles (03/2006 - 08/2003)
9. Fracasso, P M: 4 articles (07/2005 - 03/2000)
10. Litchman, M: 4 articles (05/2001 - 03/2000)

Related Diseases

1. Neoplasms (Cancer)
2. Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
3. Leukemia
4. Ovarian Neoplasms (Ovarian Cancer)
5. Ovarian Epithelial Carcinoma

Related Drugs and Biologics

1. valspodar (PSC 833)
2. Doxorubicin (Adriamycin)
3. Etoposide (VP 16)
4. Member 1 Subfamily B ATP Binding Cassette Transporter
5. Paclitaxel (Taxol)
6. Cytarabine (Cytosar-U)
7. Cyclosporine (Ciclosporin)
8. Daunorubicin (Cerubidine)
9. Mitoxantrone (Novantrone)
10. Carboplatin (JM8)

Related Therapies and Procedures

1. Therapeutics
2. Drug Therapy (Chemotherapy)
3. Induction Chemotherapy
4. Drug Tapering
5. Intravenous Administration